- Antibody Type
- Recombinant monoclonal
- Target
- Symmetric Di-Methyl Arginine
- Reactivity
- Species Independent
- Application
- WB, IHC, ELISA
- MW(Calculated)
- Multiple
- MW(Observed)
- Multiple
- Host Species
- Rabbit
- Isotype
- IgG
- Conjugate
- Unconjugated
- Modification
- Symmetric Dimethylation of Arginine
- Modification Site
- Arg (R)
- Recommended dilution ratio
- WB 1:1000;IHC-P 1:2000
- Composition
- PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide
- Purification process
- Protein A
- storageCondition
- Store at -20°C. Avoid repeated freeze-thaw cycles
- Stability
- Stable for 12 months from date of receipt / reconstitution.
- Concentration
- 1 mg/ml
- Clonal
- Recombinant monoclonal
- Clone Number
- --
- Immunogen
- Synthetic Peptide
- Gene Name
- --
- Protein Name
- --
- Alternative name
- Rme2 (sy)
- Organism-1
- --
- Gene ID
- --
- SwissProt-1
- --
- --
- Background:
- Background
- Histones and non-histone proteins are subjected to a variety of enzyme-catalyzed post-translational modifications, including acetylation, methylation, phosphorylation and ubiquitination. Symmetric dimethyl arginine (SDMA) is an important arginine methylation mark catalyzed primarily by type II protein arginine methyltransferases. It is widely distributed in eukaryotic cells and abundantly present in chromatin proteins, RNA-binding factors and signal transduction molecules. SDMA participates in the regulation of chromatin remodeling, gene transcription, RNA splicing, DNA damage response and cell fate determination. Dysregulation of symmetric arginine dimethylation is closely linked to inflammation, tumorigenesis, cardiovascular disorders and neurodegenerative diseases, serving as a critical epigenetic marker for biological mechanism research and disease pathological study.
- Cellular Localization
- --
- --
- Background:Histones and non-histone proteins are subjected to a variety of enzyme-catalyzed post-translational modifications, including acetylation, methylation, phosphorylation and ubiquitination. Symmetric dimethyl arginine (SDMA) is an important arginine methylation mark catalyzed primarily by type II protein arginine methyltransferases. It is widely distributed in eukaryotic cells and abundantly present in chromatin proteins, RNA-binding factors and signal transduction molecules. SDMA participates in the regulation of chromatin remodeling, gene transcription, RNA splicing, DNA damage response and cell fate determination. Dysregulation of symmetric arginine dimethylation is closely linked to inflammation, tumorigenesis, cardiovascular disorders and neurodegenerative diseases, serving as a critical epigenetic marker for biological mechanism research and disease pathological study.
- --
- --
- --
- --
- --
- --
- --
- --
- --
- --
- --
- --